IP Library Granted Patent US 9,487,749
Granted Patent B2
US 9,487,749 · App. 14/458,148 · Granted Nov 8, 2016

Use of methylsulfonylmethane (MSM) to modulate microbial activity

Inventors: Rodney L. Benjamin (Camas, WA); Jeffrey Varelman (Moyie Springs, ID); Anthony L. Keller (Medford, OR)
Assignee: Biogenic Innovations, LLC
C12N1/38A01N41/10A61K9/0014A61K31/10A61K31/43A61K31/431A61K31/437A61K45/06C12N1/18C12N1/20C12P7/06C12P7/56Y02E50/17Y02E50/343
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,487,749
App. No.
14/458,148
Granted
Nov 8, 2016
Kind
B2
Abstract

Disclosed herein are methods of use of methylsulfonylmethane (MSM) to modulate microbial activity, such as to enhance or inhibit the activity of microorganisms. In one example, MSM (such as about 0.5% to 5% MSM) is used to enhance fermentation efficiency, such as to enhance fermentation efficiency associated with the production of beer, cider, wine, a biofuel, dairy product or any combination thereof. Also disclosed are in vitro methods for enhancing the growth of one or more probiotic microorganisms and methods of enhancing growth of a microorganism in a diagnostic test sample. Methods of inhibiting microbial activity are also disclosed. In one particular example, a method of inhibiting microbial activity includes selecting a medium that is susceptible to H1N1 influenza contamination; and contacting the medium with MSM at a concentration of about 10% to about 16% of weight by volume, thereby inhibiting H1N1 influenza microbial activity.

Claims (28)

1. An in vitro method of enhancing growth of bacteria, the method comprising:

contacting in vitro (1) bacteria in fermentation medium capable of supporting growth of the bacteria with (2) methylsulfonylmethane (MSM) at a concentration of 0.04% to 5% by weight of the fermentation medium,

wherein the MSM increases growth of the bacteria by at least 10% in the presence of MSM as compared to growth in the absence of MSM, and

wherein the bacteria are Bifidobacteria or lactic acid bacteria, or a mixture thereof.

2. The in vitro method of claim 1 , wherein the Bifidobacteria is Bifidobacterium bifidum.

3. The in vitro method of claim 1 , wherein the lactic acid bacteria are selected from Lactobacillus acidophilus, Lactobacillus delbrueckii, Bacillus coagulans, Lactobacillus rhamnosus , or any combination thereof.

4. The in vitro method of claim 1 , wherein the fermentation medium comprises a sugar.

5. The in vitro method of claim 1 , wherein the fermentation medium comprises milk.

6. The in vitro method of claim 1 , wherein the fermentation medium comprises less than 5% sodium chloride.

7. The in vitro method of claim 1 , wherein the lactic acid bacteria are Lactobacillus acidophilus and the fermentation medium comprises milk.

8. The in vitro method of claim 1 , wherein the MSM increases the growth of the bacteria by at least 20%.

9. The in vitro method of claim 1 , wherein the MSM increases the growth of the bacteria by at least 50%.

10. The in vitro method of claim 1 , wherein the concentration of the MSM is 0.04% by weight of the fermentation medium.

11. The in vitro method of claim 1 , wherein the concentration of the MSM is 0.1% by weight of the fermentation medium.

12. The in vitro method of claim 1 , wherein the concentration of the MSM is 0.2% by weight of the fermentation medium.

13. The in vitro method of claim 1 , wherein the concentration of the MSM is 0.25% by weight of the fermentation medium.

14. The in vitro method of claim 1 , wherein the concentration of the MSM is 0.4% by weight of the fermentation medium.

15. The in vitro method of claim 1 , wherein the concentration of the MSM is 2.5% by weight of the fermentation medium.

16. The in vitro method of claim 1 , wherein the MSM increases growth of the bacteria by:

at least 10% in the presence of MSM as compared to growth in the absence of MSM when measured as increase in turbidity;

at least 100% in the presence of MSM as compared to growth in the absence of MSM when measured as population weight average; or

at least 10% in the presence of MSM as compared to growth in the absence of MSM when measured as log growth.

17. An in vitro method of enhancing growth of Lactobacillus acidophilus, Lactobacillus rhamnosus , or Bifidobacterium bifidum , the method comprising:

contacting, in vitro, (1) Lactobacillus acidophilus, Lactobacillus rhamnosus , or Bifidobacterium bifidum in fermentation medium capable of supporting growth of the Lactobacillus acidophilus, Lactobacillus rhamnosus , or Bifidobacterium bifidum , with (2) methylsulfonylmethane (MSM) at a concentration of 0.04% to 1% by weight of the fermentation medium,

wherein the MSM increases growth of the Lactobacillus acidophilus, Lactobacillus rhamnosus , or Bifidobacterium bifidum by at least 10% in the presence of MSM as compared to growth in the absence of MSM.

18. An in vitro method for enhancing growth of Bacillus coagulans , the method comprising:

contacting, in vitro, (1) Bacillus coagulans in fermentation medium capable of supporting growth of the Bacillus coagulans , with (2) methylsulfonylmethane (MSM) at a concentration of 1%, 2.5%, or 5% by weight of the fermentation medium,

wherein the MSM increases growth of the Bacillus coagulans by at least 100% in the presence of MSM as compared to growth in the absence of MSM.

Assignments (4)
SECURITY INTEREST Recorded Jul 24, 2026
From: ALBION LABORATORIES, INC.; BALCHEM CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075393/0698 →
MERGER Recorded Jun 11, 2024
From: CARDINAL ASSOCIATES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 067695/0404 →
ASSET ASSIGNMENT AGREEMENT Recorded Jun 11, 2024
From: BIOGENIC INNOVATIONS, LLC
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 067698/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 033540/0093 →
Continuity (7)
Continuation 13029001 · Feb 16, 2011
Continuation PCTUS2010054845 · Oct 29, 2010
Provisional Application 61294437 · Jan 12, 2010
Provisional Application 61259098 · Nov 6, 2009
Provisional Application 61257751 · Nov 3, 2009
Provisional Application 61256935 · Oct 30, 2009
Related Publication 20140349375A1 · Nov 27, 2014